These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 33155015)
1. Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening. Zilla M; Wheeler BJ; Keetch C; Mitchell G; McBreen J; Wells A; Shurin MR; Peck-Palmer O; Wheeler SE Am J Clin Pathol; 2021 Feb; 155(3):343-353. PubMed ID: 33155015 [TBL] [Abstract][Full Text] [Related]
2. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program. Wendel S; Kutner JM; Machado R; Fontão-Wendel R; Bub C; Fachini R; Yokoyama A; Candelaria G; Sakashita A; Achkar R; Hamerschlak N; Scuracchio P; Amaral M; Dal Ben M; Araujo D; Soares C; Camargo A; Kallás E; Durigon E; Reis LF; Rizzo LV Transfusion; 2020 Dec; 60(12):2938-2951. PubMed ID: 32935877 [TBL] [Abstract][Full Text] [Related]
3. Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels. Harvala H; Robb ML; Watkins N; Ijaz S; Dicks S; Patel M; Supasa P; Wanwisa D; Liu C; Mongkolsapaya J; Bown A; Bailey D; Vipond R; Grayson N; Temperton N; Gupta S; Ploeg RJ; Bolton J; Fyfe A; Gopal R; Simmonds P; Screaton G; Thompson C; Brooks T; Zambon M; Miflin G; Roberts DJ Transfus Med; 2021 Jun; 31(3):167-175. PubMed ID: 33333627 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays. Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N; Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976 [TBL] [Abstract][Full Text] [Related]
5. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Van Elslande J; Decru B; Jonckheere S; Van Wijngaerden E; Houben E; Vandecandelaere P; Indevuyst C; Depypere M; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P Clin Microbiol Infect; 2020 Nov; 26(11):1557.e1-1557.e7. PubMed ID: 32745595 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera. Ha B; Jadhao S; Hussaini L; Gibson T; Stephens K; Salazar L; Ciric C; Taylor M; Rouphael N; Edupuganti S; Rostad CA; Tompkins SM; Anderson EJ; Anderson LJ Microbiol Spectr; 2021 Oct; 9(2):e0045821. PubMed ID: 34494855 [TBL] [Abstract][Full Text] [Related]
7. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population. Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691 [TBL] [Abstract][Full Text] [Related]
8. A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays. Poore B; Nerenz RD; Brodis D; Brown CI; Cervinski MA; Hubbard JA Clin Biochem; 2021 Sep; 95():77-80. PubMed ID: 34118242 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India. Jain R; Mallya MV; Amoncar S; Palyekar S; Adsul HP; Kumar R; Chawla S Transfus Clin Biol; 2022 Feb; 29(1):60-64. PubMed ID: 34302953 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies. Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593 [TBL] [Abstract][Full Text] [Related]
12. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers. Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods. Theel ES; Johnson PW; Kunze KL; Wu L; Gorsh AP; Granger D; Roforth MM; Jerde CR; Lasho M; Andersen KJ; Murphy BM; Harring J; Lake DF; Svarovsky SA; Senefeld JW; Carter RE; Joyner MJ; Baumann NA; Mills JR J Clin Microbiol; 2021 Aug; 59(9):e0123121. PubMed ID: 34166066 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months. Robertson LJ; Moore JS; Blighe K; Ng KY; Quinn N; Jennings F; Warnock G; Sharpe P; Clarke M; Maguire K; Rainey S; Price RK; Burns WP; Kowalczyk AM; Awuah A; McNamee SE; Wallace GE; Hunter D; Sager S; Chao Shern C; Nesbit MA; McLaughlin JAD; Moore T BMJ Open; 2021 Jun; 11(6):e048142. PubMed ID: 34187827 [TBL] [Abstract][Full Text] [Related]
15. High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples. Anand SP; Prévost J; Richard J; Perreault J; Tremblay T; Drouin M; Fournier MJ; Lewin A; Bazin R; Finzi A Transfusion; 2021 May; 61(5):1377-1382. PubMed ID: 33604922 [TBL] [Abstract][Full Text] [Related]